(Q54146290)

25 May 2018

title

Linear IgA bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy. (English)

1 reference

25 May 2018

linear IgA bullous dermatosis

1 reference

1 reference

Khan IU

1

1 reference

25 May 2018

Bhol KC

series ordinal

2

1 reference

25 May 2018

Ahmed AR

series ordinal

3

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

25 May 2018

Journal of the American Academy of Dermatology

published in

1 reference

25 May 2018

volume

40

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

485-488

1 reference

25 May 2018

Linear IgA disease: a heterogeneous disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Detection of autoantibody against 97-kD antigen by immunoblot, but not by indirect immunofluorescence, in a patient with linear IgA bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

IgA mesangial nephropathy and autoimmune haemolytic anaemia associated with linear IgA bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Comparison of an indirect immunofluorescence assay and a modified sensitive immunoblot assay for the study of the autoantibody in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Suppression of Cytokine-Dependent Human T-Cell Proliferation by Intravenous Immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970504-9

7 January 2021

10.1016/S0190-9622(99)70504-9

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018